Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v2-EN
Language English English
Date Updated 2019-09-12 2019-09-11
Drug Identification Number 02344939 02344939
Brand name ILARIS ILARIS
Common or Proper name ILARIS 150MG 1X1 VIAL ILARIS 150MG 1X1 VIAL
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients CANAKINUMAB CANAKINUMAB
Strength(s) 150MG 150MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 X 1 1 X 1
ATC code L04AC L04AC
ATC description IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-09-11 2019-09-11
Remaining supply date 2019-09-11 2019-09-11
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Replaced with ILARIS 150MG 1X1 LIQ VIAL - DIN #02460351 - Product Code 736120 Replaced with ILARIS 150MG 1X1 LIQ VIAL - DIN #02460351 - Product Code 736120
Health Canada comments